SNA 135.12 Snap-On Inc $SNA Hit a 52 week high of 137.43

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 1:53 PM

SNA 135.12 Snap-On Inc $SNA Hit a 52 week high of 137.43 Currently at 135.12 -0.48 -0.35% With a day low of 134.14 and a total volume of 898,400.

SNA Snap-On Inc Recent Headline News

Snap-on announces 20.5% higher dividend of USD0.53 per share for quarter
M2 - Fri Nov 07, 6:17AM CST
Snap-on Incorporated (NYSE:SNA) reported on Friday that its board of directors approved a quarterly common stock dividend of USD0.53 per share.
SNA: 135.12 (-0.48)

Snap-on Raises Dividend 20.5%
Business Wire - Thu Nov 06, 3:54PM CST
Snap-on Incorporated (NYSE: SNA) today announced that its Board of Directors has declared a quarterly common stock dividend of $0.53 per share payable December 10, 2014, to shareholders of record on November 24, 2014. This represents an increase of $0.09 per share, or 20.5%, over Snap-on's previous quarterly dividend of $0.44 per share.
SNA: 135.12 (-0.48)

Snap-on to Present at Baird Industrial Conference
Business Wire - Mon Nov 03, 11:09AM CST
Snap-on Incorporated (NYSE: SNA) will present at the Robert W. Baird & Co. 2014 Industrial Conference on Wednesday, November 12, 2014. The presentation is scheduled to begin at approximately 9:00 a.m. Eastern (8:00 a.m. Central).
SNA: 135.12 (-0.48)

Stanley Black & Decker Q3 Earnings Crush Views
at Investor's Business Daily - Wed Oct 22, 11:25AM CDT
Stanley Black & Decker crushed third-quarter earnings views and topped revenue expectations as growth in its consumer do-it-yourself segment surged in both North America and Europe. Third-quarter earnings per share increased 13% to $1.55 a share....
SWK: 95.01 (+0.61), SNA: 135.12 (-0.48)

Company News for October 17, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:10AM CDT
Companies in the News are: MAT,SNA,ADS,KMI
KMI: 38.75 (+0.22), SNA: 135.12 (-0.48), MAT: 31.67 (+0.18), ADS: 283.61 (-1.37)

Snap-On
at Investor's Business Daily - Thu Oct 16, 5:51PM CDT
Snap-On (SNA) earned $1.76 a share in Q3, rising 23% from a year earlier and beating analysts' views by 33 cents. Revenue rose 14% to $859.9 mil, also beating views. Shares rose 6% to 121.39 and Snap-On's stock is up 11% for the year.
SNA: 135.12 (-0.48)

Snap-on (SNA) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Oct 16, 5:10PM CDT
The following Snap-on (SNA) conference call took place on October 16, 2014, 10:00 AM ET. This is a transcript of that earnings call:
SNA: 135.12 (-0.48)

Snap-on Tops Earnings & Revenues on Strong Segment Show - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 10:10AM CDT
Snap-on Inc. (SNA) reported strong third-quarter 2014 results with healthy growth in net sales and earnings.
NDSN: 77.64 (+0.46), SNA: 135.12 (-0.48), B: 36.42 (-0.08), MIDD: 94.00 (+1.79)

Snap-On posts 3Q profit
Automated Insights - Thu Oct 16, 6:15AM CDT
KENOSHA, Wis. (AP) _ Snap-On Inc. (SNA) on Thursday reported earnings of $103.7 million, or $1.76 per share, in its third quarter.
SNA: 135.12 (-0.48)

Snap-on Announces Third Quarter 2014 Results
Business Wire - Thu Oct 16, 6:00AM CDT
Snap-on Incorporated (NYSE: SNA), a leading global innovator, manufacturer and marketer of tools, equipment, diagnostics, repair information and systems solutions for professional users performing critical tasks, today announced operating results for the third quarter of 2014.
SNA: 135.12 (-0.48)

Will Snap-on Inc. (SNA) Keep the Earnings Streak Alive? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 10:40AM CDT
Snap-on Inc. (SNA) is set to report third-quarter 2014 results on Oct 16 before the opening bell.
HCA: 65.75 (-3.22), CW: 69.66 (-0.12), SNA: 135.12 (-0.48), AAPL: 109.01 (+0.31)

Snap-on Incorporated to Webcast 2014 Third Quarter Results Conference Call
Business Wire - Thu Oct 02, 11:15AM CDT
Snap-on Incorporated (NYSE: SNA) will release 2014 third quarter results prior to the market open on Thursday, October 16, 2014. A conference call to discuss the results will be held at 10:00am ET on that day. The conference call, with accompanying slides, will be webcast live via the Internet.
SNA: 135.12 (-0.48)

Snap-On Has Returned 17.6% Since SmarTrend Recommendation (SNA)
Comtex SmarTrend(R) - Fri Sep 26, 9:17AM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 8 months, Snap-On has returned 17.63% as of today's recent price of $120.78.
SNA: 135.12 (-0.48)

Snap-On Up 22.1% Since SmarTrend Uptrend Call (SNA)
Comtex SmarTrend(R) - Thu Sep 18, 4:43PM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 7 months, Snap-On has returned 22.07% as of today's recent price of $125.33.
SNA: 135.12 (-0.48)

Snap-On Shares Up 21.8% Since SmarTrend's Buy Recommendation (SNA)
Comtex SmarTrend(R) - Thu Sep 11, 11:01AM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 7 months, Snap-On has returned 21.80% as of today's recent price of $125.05.
SNA: 135.12 (-0.48)

Fitch Affirms Snap-on Inc.'s IDR at 'A-'; Outlook Stable
Business Wire - Mon Sep 08, 3:16PM CDT
Fitch Ratings has affirmed the ratings for Snap-on Inc. (NYSE: SNA), including the company's Issuer Default Rating (IDR) at 'A-'. The Rating Outlook is Stable. A complete list of rating actions follows at the end of this release.
SNA: 135.12 (-0.48)

Snap-On Has Returned 23.5% Since SmarTrend Recommendation (SNA)
Comtex SmarTrend(R) - Thu Sep 04, 9:40AM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 7 months, Snap-On has returned 23.46% as of today's recent price of $126.76.
SNA: 135.12 (-0.48)

Global Automotive Diagnostic Scan Tools Market Report 2014-2018
M2 - Thu Sep 04, 3:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lx94wg/global_automotive) has announced the addition of the "Global Automotive Diagnostic Scan Tools Market 2014-2018" report to their offering. The Global Automotive Diagnostic Scan Tools market will grow at a CAGR of 5.2% over the period 2014-2018. The automotive diagnostic scan tools were then used to diagnose any fault in a vehicle by plugging the cable into the vehicle's diagnostic connector and running a full scan. The major advantage of diagnostic scan tools is that it is easy to identify the fault and rectify it more quickly. To calculate the market size, the report covers revenue generated from the sales of OEM and aftermarket automotive diagnostic scan tools. It also presents the vendor landscape and a corresponding detailed analysis of the leading four vendors in the market. In addition, the report discusses the major drivers that influence the growth of the Global Automotive Diagnostic Scan Tools market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The presence of high-end vehicle manufacturers in developing countries is one of the major trends in the market. The Global Automotive market is poised to experience consistent growth in developing countries, which are witnessing a high adoption of vehicles from the Mid Car and Small Car segments. Vehicles in these segments use advanced electronic devices that require workshops to have diagnostic scan tools as standard equipment. According to the report, increased usage of electronic devices in vehicles is one of the major factors driving the Global Automotive Diagnostic Scan Tools market. Electronic devices in vehicles improve drivability, enhance safety features, lower environmental pollution, and provide greater operational efficiency. Further, the report states that the increased complexity of automotive electronic architecture poses a challenge for market growth. Automotive manufacturers provide advanced electronic devices for brand differentiation. As the complexity of architecture in these electronic devices differs from model to model, diagnostic scan tool manufacturers try to provide a universal diagnostic tool. Key Vendors - Denso Corp. - Snap-On Inc. - SPX Corp. - Softing AG Other Prominent Vendors - Actia Group SA - Avl List GmbH - Dg Technologies - Dsa Daten- Und Systemtechnik GmbH - Etas GmbH - General Technologies Corp - Hickok Inc. For more information visit http://www.researchandmarkets.com/research/lx...automotive
SPW: 92.86 (-0.08), SNA: 135.12 (-0.48)

Snap-on to Present at RBC Capital Markets' 2014 Global Industrials Conference
Business Wire - Tue Sep 02, 3:55PM CDT
Snap-on Incorporated (NYSE: SNA) will present at the 2014 RBC Capital Markets' Global Industrials Conference at 1:20 PM Pacific Time on Tuesday, September 9, 2014.
SNA: 135.12 (-0.48)

20.7% Return Seen to Date on SmarTrend Snap-On Call (SNA)
Comtex SmarTrend(R) - Thu Aug 28, 9:14AM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 7 months, Snap-On has returned 20.66% as of today's recent price of $123.88.
SNA: 135.12 (-0.48)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....